Back to Results
First PageMeta Content
Biotechnology / Chemical pathology / Genomics / Hepatocellular carcinoma / Proteomics / AFP-L3 / Ovarian cancer / EDRN / Imaging biomarker / Medicine / Biology / Biomarkers


Biomarkers of diseases in medicine MANOJ KUMAR1 and SHIV K SARIN1,2 1 Department of Hepatology, G B Pant Hospital and Institute of Liver and Biliary Sciences, New Delhi[removed], India.
Add to Reading List

Document Date: 2010-02-23 07:02:05


Open Document

File Size: 320,24 KB

Share Result on Facebook

City

specificity / New Delhi / /

Company

PET / /

Country

United States / India / /

/

Facility

National Cancer Institute / Institute of Liver / G B Pant Hospital / /

IndustryTerm

throughput technologies / proteomic technologies / Computer-aided diagnostic systems / functional imaging / Nuclear medicine-based imaging modalities / analytical tools / discovery using high-throughput technology platforms / nger printing / different high-throughput technologies / monitor for recurrent disease / artificial neural networks / similar technologies / increased economic healthcare burden / tissue microarray technologies / treatment of breast cancer / anatomical site / highthroughput technologies / genetic algorithms / nuclear medicine imaging / exible technologies / multidimensional protein-identification technology / supervised algorithms / optical imaging / computer decision support systems / vector machine-learning algorithms / /

MarketIndex

PGAA / PGA / /

MedicalCondition

adenomatous polyposis coli / recurrent diseases / rare diseases / positive Biomarker negative Disease present Disease / colorectal cancer / metastasis / welldifferentiated tumours / colon cancers / clinical breast cancers / colon cancer / leukaemia / squamous cell carcinoma antigen / respective diseases / benign prostatic hyperplasia / same cancers / renal cell carcinoma / prostate cancer / MS / breast cancer / colon carcinomas / carcinoid / recurrent disease / sepsis / lung cancers / cancers / high-grade tumours / several cancers / insulin resistance / cancer / CHD / disease / asymptomatic disease / both rare and common cancers / gastrointestinal stromal tumours / hepatocellular carcinoma / sub-clinical atherosclerosis / chronic liver disease / carcinogenesis / retinoblastoma gene / Fraumeni syndrome / non-malignant diseases / sporadic cancers / tumour / diabetes / lymphomas / breast and ovarian cancer / lung cancer / D Disease / autoimmune disease / diseases / extrahepatic metastases / specific disease / Carcinoid tumours / soft-tissue sarcomas / ovarian abdominal carcinomas / increased cancer / tumours / /

MedicalTreatment

adjuvant chemotherapy / chemoprevention / chemotherapy / surgery / counselling / neo-adjuvant therapy / /

OperatingSystem

L3 / /

Organization

National Cancer Institute / Pant Hospital / Institute of Liver and Biliary Sciences / Department of Hepatology / International Union Against Cancer / Department of Gastroenterology / TNM Committee / Institute of Liver / /

Person

SHIV K SARIN / Gene Chips / MANOJ KUMAR / /

Position

investigator / independent data manager / reviewing pathologist / pathologist / /

Product

IL-6 / mercaptopurine / indium / indocyanine green / sorbitol / /

ProvinceOrState

Mississippi / /

Technology

alpha / quantum dots / genomics / Pharmacogenomic / drug metabolism / proteomics / bioinformatics / X-ray / tomography / diagnostic tests / hybridization / multidimensional protein-identification technology / ultrasound / Transcriptomics / transplantation / exible technologies / high-throughput technologies / human genome / apoptosis / MRI / laser / single nucleotide polymorphism / tissue microarray technologies / DNA Chip / gene expression / chemotherapy / highthroughput technologies / radio frequency / vector machine-learning algorithms / Metabolomics / 5.1 High-throughput technologies / gel electrophoresis / CVD / different high-throughput technologies / CAD / /

SocialTag